Holen Sie sich die Stockscreener-App
1.36
5.43%
0.07
Handel nachbörslich:
1.34
-0.02
-1.47%
Schlusskurs vom Vortag:
$1.29
Offen:
$1.33
24-Stunden-Volumen:
808.20K
Relative Volume:
1.60
Marktkapitalisierung:
$103.81M
Einnahmen:
$4.29M
Nettoeinkommen (Verlust:
$-104.03M
KGV:
-0.6909
EPS:
-1.9685
Netto-Cashflow:
$-50.65M
1W Leistung:
+8.80%
1M Leistung:
+6.25%
6M Leistung:
-11.69%
1J Leistung:
-7.48%
1-Tages-Spanne:
$1.28
$1.41
1-Wochen-Bereich:
$1.18
$1.41
52-Wochen-Spanne:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.36 | 103.81M | 4.29M | -104.03M | -50.65M | -1.9685 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Cibus Inc (CBUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cibus Inc (CBUS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cibus Inc (CBUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cibus Inc (CBUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cibus Inc (CBUS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cibus Inc (CBUS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cibus Inc (CBUS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cibus Inc (CBUS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cibus Inc (CBUS) Institutional Confidence - TradingKey
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus - GlobeNewswire
Cibus Inc. (CBUS) Slides 1.6% as Stock Tests Key Support Near $1.17Merger Arbitrage - newsline.com
Cibus names board member Craig Wichner as new CEO - MSN
Cibus (CBUS) CEO receives 894K RSUs and 1.05M stock options grant - Stock Titan
Cibus, Inc. Appoints Craig Wichner as CEO to Lead Next Phase of Growth and Innovation in Agricultural Biotechnology - Minichart
Cibus Resets Leadership and Board to Drive Commercialization - TipRanks
Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO - Stock Titan
Cibus Names Board Member Craig Wichner as CEO - Moomoo
Cibus appoints Craig Wichner as chief executive officer By Investing.com - Investing.com Australia
Cibus (CBUS) Announces Leadership Changes - GuruFocus
Cibus Appoints New CEO to Drive Commercialization - Intellectia AI
Cibus appoints Craig Wichner as chief executive officer - Investing.com
Cibus, Inc. Announces Leadership Transition with Appointment of Craig Wichner as CEO - Quiver Quantitative
Farmland investor Craig Wichner becomes Cibus CEO, targets commercialization - Stock Titan
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation - Sahm
Cibus Q1 earnings call highlights - MSN
Cibus Stockholders Approve Directors and Governance Measures - The Globe and Mail
Cibus, Inc. 2026 Annual Meeting Results: Director Elections, Executive Compensation Approval, and Auditor Ratification (Form 8-K) – Minichart - Minichart
Cibus (CBUS) 2026 meeting backs board slate, executive pay and BDO - Stock Titan
Cibus (CBUS) director receives grant of 77,586 stock options - Stock Titan
Cibus (CBUS) director Moretti granted 77,586 options at $1.39 strike - Stock Titan
Stock option grant for Cibus (CBUS) director Rory B. Riggs - Stock Titan
Cibus (CBUS) director Gerhard Prante awarded 64,748 RSUs in equity grant - Stock Titan
Cibus (NASDAQ: CBUS) director awarded 64,748 RSUs in new stock grant - Stock Titan
Cibus (CBUS) director Kimberly Ann Box receives 77,586 stock options at $1.39 strike - Stock Titan
Cibus (CBUS) director Craig Wichner granted 77,586 stock options at $1.39 strike - Stock Titan
Director Urban Thomas awarded 64,748 Cibus (CBUS) shares in Form 4 filing - Stock Titan
Cibus (CBUS) upgraded to buy: What does it mean for the stock? - MSN
Cibus Inc. Q1 2026 Earnings: Smaller-Than-Expected Loss, Stock Edges LowerEPS Surprise History - newsline.com
Cibus outlines runway into late Q1 2027 while shifting US rice launch to 2029 - MSN
Cibus Global LLC (NASDAQ: CBUS) Share Price, CBUS Stock News, CBUS Share Price & Updates - Kalkine
Cibus Inc. Q1 2026 Earnings: Narrowed Loss Surprises Estimates Amid Pre-Revenue ProgressEarnings Trend Analysis - The Legal Advocate
[EFFECT] Cibus, Inc. SEC Filing - Stock Titan
Cibus Inc. Q1 2026 Earnings: Narrowing Losses Amid Pre-Revenue PhaseAdjusted Earnings Analysis - The Legal Advocate
Cibus Inc. (CBUS) Holds Steady at $1.38 as Consolidation Continues Near Support LevelsStock Buy Zone - The Legal Advocate
Cibus (CBUS) registers 10.74M shares issuable on warrants — issuer to receive proceeds - Stock Titan
Cibus (NASDAQ: CBUS) files at‑the‑market $50M shelf with Jefferies - Stock Titan
Cibus Inc. (CBUS) Faces Selling Pressure as Shares Test Key Support ZoneOBV Breakout - The Legal Advocate
CBUS SEC FilingsCIBUS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Cibus, Inc. (NASDAQ:CBUS) Q1 2026 Earnings Call Transcript - Insider Monkey
Cibus Earnings Call: Cash Extended, Execution Critical - TipRanks
CBUS Technical Analysis | Trend, Signals & Chart Patterns | CIBUS INC (NASDAQ:CBUS) - ChartMill
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):